Dr. Matthew “Oki” O’Connor in Berlin at Undoing Aging 2019. There, he debuted the Underdog Project to the public: a novel approach to attack the leading cause of death.
Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol
Cyclarity Therapeutics May 14, 2026
We are excited to share that Cyclarity revealed Phase 1 clinical trial results for UDP-003 last night, presented at the American Heart Association Vascular Discovery Scientific Sessions by our VP of Biology, Daniel Clemens.